Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Ahern

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Epidemiology (Cambridge, Mass.)|November 22, 2024
Adjusting Adjustments: Using External Data to Estimate the Impact of Different Confounder Sets on Published AssociationsThomas P Ahern, Lindsay J Collin, Richard F MacLehose, et al.
Clinical Epidemiology|December 15, 2010
Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissueThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Vascular Medicine (London, England)|November 20, 2018
Postoperative opioid prescribing patterns and use after vascular surgeryIlsley B Colton, Mayo H Fujii, Thomas P Ahern, et al.
Cancer|July 25, 2015
Opioids and breast cancer recurrence: A Danish population-based cohort studyDeirdre P Cronin-Fenton, Uffe Heide-Jørgensen, Thomas P Ahern, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 14, 2026
Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast CancersShuai Chen, Karla Kerlikowske, Yu-Ru Su, et al.
Critical Reviews in Eukaryotic Gene Expression|June 24, 2024
A MicroRNA Approach to Evaluating Elevated Prostate Cancer Risk in Cancer-Free MenScott D Perrapato, Nicholas H Farina, Adrian N Berg, et al.
Scientific Reports|August 12, 2017
CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium datasetPer Damkier, Anders Kjærsgaard, Kimberly A Barker, et al.
Journal of the National Cancer Institute|February 18, 2022
Medication-Associated Phthalate Exposure and Childhood Cancer IncidenceThomas P Ahern, Logan G Spector, Per Damkier, et al.
American Journal of Epidemiology|July 9, 2020
Bayesian Pathway Analysis for Complex InteractionsJames W Baurley, Anders Kjærsgaard, Michael E Zwick, et al.
Oncotarget|January 20, 2018
Development of a predictive miRNA signature for breast cancer risk among high-risk womenNicholas H Farina, Jon E Ramsey, Melissa E Cuke, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Epidemiology (Cambridge, Mass.)|November 22, 2024
Adjusting Adjustments: Using External Data to Estimate the Impact of Different Confounder Sets on Published AssociationsThomas P Ahern, Lindsay J Collin, Richard F MacLehose, et al.
Clinical Epidemiology|December 15, 2010
Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissueThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Vascular Medicine (London, England)|November 20, 2018
Postoperative opioid prescribing patterns and use after vascular surgeryIlsley B Colton, Mayo H Fujii, Thomas P Ahern, et al.
Cancer|July 25, 2015
Opioids and breast cancer recurrence: A Danish population-based cohort studyDeirdre P Cronin-Fenton, Uffe Heide-Jørgensen, Thomas P Ahern, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 14, 2026
Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast CancersShuai Chen, Karla Kerlikowske, Yu-Ru Su, et al.
Critical Reviews in Eukaryotic Gene Expression|June 24, 2024
A MicroRNA Approach to Evaluating Elevated Prostate Cancer Risk in Cancer-Free MenScott D Perrapato, Nicholas H Farina, Adrian N Berg, et al.
Scientific Reports|August 12, 2017
CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium datasetPer Damkier, Anders Kjærsgaard, Kimberly A Barker, et al.
Journal of the National Cancer Institute|February 18, 2022
Medication-Associated Phthalate Exposure and Childhood Cancer IncidenceThomas P Ahern, Logan G Spector, Per Damkier, et al.
American Journal of Epidemiology|July 9, 2020
Bayesian Pathway Analysis for Complex InteractionsJames W Baurley, Anders Kjærsgaard, Michael E Zwick, et al.
Oncotarget|January 20, 2018
Development of a predictive miRNA signature for breast cancer risk among high-risk womenNicholas H Farina, Jon E Ramsey, Melissa E Cuke, et al.
Pageof 11